Zhiyong Li

5PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2023
Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinoma.

Xin An, Cong Xue, Meiting Chen

|Jun 15, 2022
First-line programmed death receptor-1 (PD-1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum-based chemotherapy, for stage IV penile cancer.

Ru Yan, Huali Ma, Lijuan Jiang

|Apr 27, 2022
Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis.

Zeshen Wu, Yulu Peng, Longbin Xiong

|Nov 24, 2021
Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.

Zhiyong Li, Lijuan Jiang, Zhiling Zhang

|Dec 30, 2017
Proposal for reclassification of N staging system in penile cancer patients, based on number of positive lymph nodes.

Zhiyong Li, Shengjie Guo, Zhiming Wu

Pageof 1

Frequent Collaborators

2 joint publications

Zhuowei Liu

1 joint publications

Shengjie Guo

1 joint publications

Zeshen Wu

1 joint publications

Yulu Peng